Related Experiment Video
Updated: Jun 23, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
Association between GPx1 Pro198Leu polymorphism, GPx1 activity and plasma selenium concentration in humans
E Jablonska1, J Gromadzinska, E Reszka
1Department of Toxicology and Carcinogenesis, Nofer Institute of Occupational Medicine, Lodz, Poland. ewa@imp.lodz.pl
The GPx1 Pro198Leu polymorphism influences how glutathione peroxidase 1 (GPx1) enzyme activity responds to selenium (Se) levels in healthy individuals. This genetic variation impacts GPx1 activity, highlighting the importance of genetic background in assessing selenium status.
Area of Science:
- Biochemistry
- Genetics
- Nutritional Science
Background:
- Glutathione peroxidase 1 (GPx1) is a crucial antioxidant selenoenzyme protecting cells from reactive oxygen species.
- GPx1 activity is dependent on selenium (Se) concentration, with a known genetic polymorphism (Pro198Leu) potentially affecting its function.
- Previous in vitro studies suggested the GPx1 Leu allele may reduce enzyme responsiveness to selenium.
Purpose of the Study:
- To investigate whether the GPx1 Pro198Leu polymorphism influences GPx1 enzyme activity in relation to selenium status in healthy individuals.
- To assess the functional significance of GPx1 polymorphism in the human body concerning selenium metabolism.
Main Methods:
- Studied 405 healthy individuals of Polish origin.
- Measured red blood cell GPx1 activity using spectrophotometry.
- Quantified plasma selenium concentration via graphite furnace atomic absorption spectrometry.
- Genotyped the GPx1 Pro198Leu polymorphism using Molecular Beacon Real-Time PCR.
Main Results:
- No significant differences in mean plasma selenium or GPx1 activity were observed between different GPx1 genotypes.
- However, the correlation between GPx1 activity and selenium concentration varied significantly across genotypes.
- A stronger positive correlation was found for Pro/Pro (r=0.44) and Pro/Leu (r=0.35) genotypes compared to Leu/Leu (r=0.25), with a statistically significant difference between Pro/Pro and Leu/Leu groups (p=0.034).
Conclusions:
- The GPx1 Pro198Leu polymorphism demonstrates functional significance in humans, affecting GPx1 activity's response to selenium levels.
- These findings support in vitro observations and underscore the importance of considering genetic background when using selenoprotein biomarkers like GPx1 activity to assess selenium status.
Related Concept Videos
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pleiotropy
